CBD in Food : A Challenging Road Ahead

 

Register Now

Already Registered?

Business Email*

First Name*

Last Name*

Title*

Company Name*

State/Province*    Please Select One     Non-US     Alabama     Alaska     Arizona     Arkansas     California     Colorado     Connecticut     Delaware     District of Columbia     Florida     Georgia     Hawaii     Idaho     Illinois     Indiana     Iowa     Kansas     Kentucky     Louisiana     Maine     Maryland     Massachusetts     Michigan     Minnesota     Mississippi     Missouri     Montana     Nebraska     Nevada     New Hampshire     New Jersey     New Mexico     New York     North Carolina     North Dakota     Ohio     Oklahoma     Oregon     Pennsylvania     Puerto Rico     Rhode Island     South Carolina     South Dakota     Tennessee     Texas     Utah     Vermont     Virginia     Washington     West Virginia     Wisconsin     Wyoming     AA     AE     AP     American Samoa     Federated States of Micronesia     Guam     Marshall Islands     Northern Mariana Islands     Palau     Virgin Islands     Alberta     British Columbia     Manitoba     New Brunswick     Newfoundland and Labrador     Northwest Territories     Nova Scotia     Nunavut     Ontario     Prince Edward Island     Quebec     Saskatchewan     Yukon  

Country*    Afghanistan     Albania     Algeria     American Samoa     Andorra     Angola     Anguilla     Antarctica     Antigua and Barbuda     Argentina     Armenia     Aruba     Ashmore and Cartier Islands     Australia     Austria     Azerbaijan     Bahamas, The     Bahrain     Baker Island     Bangladesh     Barbados     Bassas da India     Belarus     Belgium     Belize     Benin     Bermuda     Bhutan     Bolivia     Bosnia and Herzegovina     Botswana     Bouvet Island     Brazil     British Indian Ocean Territory     British Virgin Islands     Brunei     Bulgaria     Burkina Faso     Burundi     Cambodia     Cameroon     Canada     Cape Verde     Cayman Islands     Central African Republic     Chad     Chile     China     Christmas Island     Clipperton Island     Cocos (Keeling) Islands     Colombia     Comoros     Congo, Democratic Republic of     Cook Islands     Costa Rica     Cote d'Ivoire     Croatia     Cyprus     Czech Republic     Denmark     Djibouti     Dominica     Dominican Republic     Ecuador     Egypt     El Salvador     Equatorial Guinea     Eritrea     Estonia     Ethiopia     Europa Island     Falkland Islands     Faroe Islands     Fiji     Finland     France     French Guiana     French Polynesia     French Southern and Antarctic     Gabon     Gambia, The     Gaza Strip     Georgia     Germany     Ghana     Gibraltar     Glorioso Islands     Greece     Greenland     Grenada     Guadeloupe     Guam     Guatemala     Guernsey     Guinea     Guinea-Bissau     Guyana     Haiti     Heard and McDonald Islands     Holy See (Vatican City)     Honduras     Hong Kong     Howland Island     Hungary     Iceland     India     Indonesia     Iraq     Ireland     Israel     Italy     Jamaica     Jan Mayen     Japan     Jarvis Island     Jersey     Johnston Atoll     Jordan     Juan de Nova Island     Kazakhstan     Kenya     Kingman Reef     Kiribati     Korea, South     Kuwait     Kyrgyzstan     Lao People's Democratic Republic     Latvia     Lebanon     Lesotho     Liberia     Libya     Liechtenstein     Lithuania     Luxembourg     Macao     Macedonia     Madagascar     Malawi     Malaysia     Maldives     Mali     Malta     Man, Isle of     Marshall Islands     Martinique     Mauritania     Mauritius     Mayotte     Mexico     Micronesia, Federated States of     Midway Islands     Moldova     Monaco     Mongolia     Montserrat     Morocco     Mozambique     Myanmar     Namibia     Nauru     Navassa Island     Nepal     Netherlands     Netherlands Antilles     New Caledonia     New Zealand     Nicaragua     Niger     Nigeria     Niue     Norfolk Island     Northern Mariana Islands     Norway     Oman     Pakistan     Palau     Palmyra Atoll     Panama     Papua New Guinea     Paracel Islands     Paraguay     Peru     Philippines     Pitcairn Islands     Poland     Portugal     Puerto Rico     Qatar     Reunion     Romania     Russia     Rwanda     Saint Helena     Saint Kitts and Nevis     Saint Lucia     Saint Pierre and Miquelon     Saint Vincent and Grenadines     Samoa     San Marino     Sao Tome and Principe     Saudi Arabia     Senegal     Serbia and Montenegro     Seychelles     Sierra Leone     Singapore     Slovakia     Slovenia     Solomon Islands     Somalia     South Africa     South Georgia     South Sudan     Spain     Spratly Islands     Sri Lanka     Suriname     Svalbard     Swaziland     Sweden     Switzerland     Taiwan     Tajikistan     Tanzania     Thailand     Timor-Leste     Togo     Tokelau     Tonga     Trinidad and Tobago     Tromelin Island     Tunisia     Turkey     Turkmenistan     Turks and Caicos Islands     Tuvalu     Uganda     Ukraine     United Arab Emirates     United Kingdom     United States     Uruguay     Uzbekistan     Vanuatu     Venezuela     Vietnam     Virgin Islands     Wake Atoll     Wallis and Futuna     West Bank     Western Sahara     Yemen     Zambia     Zimbabwe  

Phone Number*

Street Address 1*

City*

Zip Code*

What are the core challenges you face when formulating with Cannabis?*

Have you tried lipids to solve any of your formulating challenges?*

Which best describes your job function?    Please Select One:     Nutritional - Corp / General Management     Nutritional - Engineering / Production / Distribut     Nutritional - Marketing     Nutritional - Package Design     Nutritional - Purchasing     Nutritional - Quality Control     Nutritional - R&D / Product Development     Nutritional - Regulatory Affairs     Nutritional - Other  

Which best describes your business/industry?    Please Select One:     Nutritional - Contract Mfg / Service Providers     Nutritional - Dietary Supplements     Nutritional - Functional / Fortified Beverages     Nutritional - Functional / Fortified Foods     Nutritional - Vitamins / Minerals     Nutritional - Other  

MJH Life Sciences Privacy Policy

*Denotes required.

You must have Javascript and Cookies enabled to access this webcast. Click here for Help.

Summary

Thursday, August 13, 2020 at 2pm EDT | 1pm CDT | 11am PDT

---

Event Overview:

The number of CBD-containing food and drinks in the market is growing even as FDA says that CBD is currently not a legal ingredient in these products. If CBD were ever to become legal in food and drinks, market experts predict that opportunities for CBD food and drinks could be significant. In this webcast, we take a look at the challenges—and opportunities—facing CBD as a food and drink ingredient. Will CBD ever become a legal food ingredient? And, if so, what do formulators need to learn to successfully work with CBD in food and beverages? Attendees will also get an updated look at what CBD food and drink products are already on the market.

 

Key Learning Objectives:

• Learn about the legal obstacles CBD faces as a food and drink ingredient
• Learn challenges and tips when formulating with CBD in food and drinks
• Learn about what the current CBD food and drink market looks like

Who Should Attend:

• General Management
• R&D / Product Development
• Regulatory / Legal
• Marketing / Creative

 

For questions please contact Martha Devia: mdevia@mjhlifesciences.com

 

Speakers

Larry Levin
Executive Vice President
Market and Shopper Intelligence, IRI

Larry has spent his entire career in market research, leading engagements for many of the world’s largest manufacturers and retailers, including Pepsi, Coke, Lexus, Porsche, Nissan, Infiniti, Starbucks, Audi, Microsoft, and Disney, just to name a few. The first three decades of his career were spent at Synovate (formerly Market Facts), where he held a number of positions, including head of Global Automotive, executive director of International New Business Development, and leader of two global conferences—one in Beijing and one in Cairo. Following his tenure at Synovate, Larry joined TNS as head of its Consumer Sector. He was quickly elevated to President of Client Services and Relations, where he and Bob Tomei, current president of IRI’s Consumer & Shopper Marketing, co-led its North American business. In February 2010, Larry joined IRI to lead its Survey Solutions group and was then promoted to run its overall Consumer Insights business. He also led IRI’s Business Development–New Solutions until he was named Executive Vice President of Consumer & Shopper Marketing in 2017. Larry is a frequent speaker at a number of industry events, including Sweets & Snacks Expo, Confections State of the Industry, NACS State of the Industry, Shopper Marketing, HOP—State of Mass Beauty, FMI, New Products Innovation, NFRA and CSPA, and he has been a guest on Bloomberg Television’s Surveillance program as well as quoted in numerous periodicals.

Kantha Shelke, PhD, CFS
Principal
Corvus Blue LLC

Kantha Shelke, PhD, CFS, is a principal at Corvus Blue LLC, a contract food science and product development firm specializing in competitive intelligence and rapid commercialization of foods, ingredients, and technologies. Kantha practices and teaches food science and safety regulations from end-to-end in global food/supplement supply chains. A Fellow of the Institute of Food Technologists, she writes for industry magazines (PLMA Live!; Prepared Foods; Food Technology), teaches in the Johns Hopkins University Master of Science Program in Food Safety Regulations, and is a member of the Faculty Advisory Board of Food and Agriculture at McGill University (Montreal) and the Faculty Advisory Board at Southwest College of Naturopathic Medicine (Tempe, AZ).

Ashish Talati
Partner
Amin Talati Wasserman LLP

Ashish Talati leads Amin Talati & Wasserman’s FDA practice and is one of the industry’s foremost experts on FDA regulatory matters.Ashish primarily counsels clients on matters of regulatory compliance, helping them anticipate and address regulatory issues in their day-to-day business operations and strategic planning. He also advocates on their behalf before the FDA, FTC, Customs, USDA, and other federal agencies. He is considered a leading authority in the areas of Generally Recognized as Safe (GRAS) requirements and New Dietary Ingredients (NDI). Considered a creative and strategic partner by his clients, Ashish works with companies all over the globe and is a trusted advisor at every step of the product life cycle, including product formulation, safety and efficacy studies, product launch, and ongoing marketing and sales.

FDA MedWatch: ChloraPrep 3 mL Applicator by BD Recall

 

MedWatch - The FDA Safety Information and Adverse Event Reporting Program

A MedWatch Safety Alert was added to the FDA Recalls webpage.  TOPIC: ChloraPrep 3 mL Applicator by BD: Recall Due to Potential Fungal Contamination with Aspergillus penicillioides in Specific U.S. Territories and Countries AUDIENCE: Patient, Health Professional, Risk Manager ISSUE: BD (Becton, Dickinson and Company) is recalling ChloraPrep 3 mL applicator due to possible fungal contamination, which only affects climate zone IV regions in specific U.S. territories and countries (see list of catalog numbers and regions impacted by this issue below). Based on internal product quality testing, BD identified that storage of the ChloraPrep 3 mL applicators exposed to temperatures of 30°C (86°F) and 75% relative humidity for more than six months can result in the growth of Aspergillus penicillioides, a type of fungus, resulting in a breach in the outer package integrity. This recall is limited to the U.S. territories and countries listed below. This recall does not affect any other ChloraPrep product presentations, regardless of geography. To date, no adverse events or deaths have been reported related to this recall.

BACKGROUND: Aspergillus penicillioides within the packaging can contaminate the surface of the applicator and/or gloved hands of the health care professional and consequently the sterile field. Contamination of skin preparation products with Aspergillus penicillioides may lead to serious systemic infection, sepsis, illness and death. If the fungus is introduced into the patient’s bloodstream during placement of an intravascular catheter, the catheter would most likely have to be removed, requiring of another procedure. Aspergillus penicillioides infection of a surgical site may result in the need for medical and surgical interventions and long-term treatment with antifungal drugs.

RECOMMENDATION: Health professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program: Complete and submit the report online. Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the form, or submit by fax to 1-800-FDA-0178.